.Pharmacolibrary.Drugs.ATC.A.A08AB01

Information

name:Orlistat
ATC code:A08AB01
route:oral
n-compartments1

Orlistat is a gastrointestinal lipase inhibitor used for the treatment of obesity. It works by inhibiting the absorption of dietary fats in the intestine. Orlistat is approved for both prescription and over-the-counter use in several countries for weight management in conjunction with a reduced-calorie diet.

Pharmacokinetics

Pharmacokinetic parameters are based on healthy adult volunteers. Orlistat, due to its minimal systemic absorption, exhibits very low plasma concentrations.

References

  1. Zhi, J, et al., & Patel, IH (1995). Review of limited systemic absorption of orlistat, a lipase inhibitor, in healthy human volunteers. Journal of clinical pharmacology 35(11) 1103–1108. DOI:10.1002/j.1552-4604.1995.tb04034.x PUBMED:https://pubmed.ncbi.nlm.nih.gov/8626884

Revisions


Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos